Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “2- HIV Infection”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT01690403
What this trial is testing

Interaction Study to Assess the Pharmacokinetic Interaction of Oral Administration of Rifapentine on ATRIPLA™ in HIV Patients

Who this might be right for
Tuberculosis
Sanofi 25
Early research (Phase 1)Study completedNCT01755754
What this trial is testing

A Trial to Assess the Functionality of Female Condom With a Silicone Elastomer Vaginal Ring

Who this might be right for
Human Immunodeficiency Virus
International Partnership for Microbicides, Inc. 160
Not applicableLooking for participantsNCT04943861
What this trial is testing

Human Immunodeficiency Virus (HIV) Food Insecurities

Who this might be right for
Food InsecuritiesCardiometabolic ComorbiditiesHIV+2 more
Wake Forest University Health Sciences 200
Not applicableNot Yet RecruitingNCT07840651
What this trial is testing

Integrating Tuberculosis Treatment Into Community Pharmacies to Improve TB/HIV Outcomes in Uganda

Who this might be right for
TB - TuberculosisHIV - Human Immunodeficiency Virus
Makerere University 124
Not applicableStudy completedNCT01298596
What this trial is testing

Cryotherapy vs. LEEP to Treat Cervical Intraepithelial Neoplasia (CIN) 2/3 Among HIV-positive Women

Who this might be right for
Cervical Intraepithelial Neoplasia
University of Washington 400
Post-approval studies (Phase 4)Study completedNCT01618305
What this trial is testing

Evaluating the Response to Two Antiretroviral Medication Regimens in HIV-Infected Pregnant Women, Who Begin Antiretroviral Therapy Between 20 and 36 Weeks of Pregnancy, for the Prevention of Mother-to-Child Transmission

Who this might be right for
HIV Infections
Westat 408
Testing effectiveness (Phase 2)Study completedNCT00000754
What this trial is testing

Phase II Study of Two Doses of Interferon Alfa-2a (IFN Alfa-2a) in Combination With Zidovudine (AZT) and Dideoxycytidine (ddC) Versus AZT and ddC Only in Patients With HIV Infection and Less Than 400 CD4 Cells/mm3

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 60
Testing effectiveness (Phase 2)Study completedNCT00343941
What this trial is testing

Tucaresol As Add-On To HAART (Highly Active Antiretroviral Therapy) In Chronic HIV-1 Infected Adults

Who this might be right for
HIV Infection
GlaxoSmithKline 45
Not applicableUnknownNCT01969461
What this trial is testing

Comparing the Effectiveness of Two Alcohol+Adherence Interventions for HIV+ Youth

Who this might be right for
HIV
Wayne State University 400
Testing effectiveness (Phase 2)Active Not RecruitingNCT06101329
What this trial is testing

Study of Lenacapavir and Emtricitabine/Tenofovir Disoproxil Fumarate (F/TDF) in Prevention of HIV in Cisgender Women in the United States (HPTN 102)

Who this might be right for
Pre-Exposure Prophylaxis of HIV Infection
Gilead Sciences 253
Testing effectiveness (Phase 2)Study completedNCT00051844
What this trial is testing

Capravirine (AG1549) in Combination With Viracept and Two NRTIs in HIV Infected Patients Who Failed an Initial NNRTI Containing Regimen

Who this might be right for
Human Immunodeficiency Virus
Pfizer 179
Testing effectiveness (Phase 2)Ended earlyNCT00385567
What this trial is testing

A Trial of PEHRG214 in HIV-Infected Patients

Who this might be right for
HIV Infections
Virionyx Corporation Limited 70
Testing effectiveness (Phase 2)Study completedNCT00002239
What this trial is testing

Compare Three Doses of T-20 When Given in Combination With Abacavir, Amprenavir, Ritonavir, and Efavirenz to HIV-Infected Adults

Who this might be right for
HIV Infections
Hoffmann-La Roche 68
Early research (Phase 1)Study completedNCT04484337
What this trial is testing

Study to Evaluate Pharmacokinetic (PK), Safety and Tolerability of Cabotegravir (CAB) 400 Milligrams Per Milliliter (mg/mL) Formulation in Healthy Adult Participants

Who this might be right for
HIV Infections
ViiV Healthcare 138
Testing effectiveness (Phase 2)Study completedNCT04295772
What this trial is testing

Doravirine/Islatravir (DOR/ISL) in Pediatric Participants With Human Immunodeficiency Virus Type 1 (HIV-1) Who Are <18 Years of Age and Weigh ≥35 kg (MK-8591A-028)

Who this might be right for
HIV-1 Infection
Merck Sharp & Dohme LLC 42
Not applicableStudy completedNCT00946556
What this trial is testing

Examining the Ability of Herpes Simplex Virus Type 2 (HSV2) Therapy to Reduce HIV Target Cell Numbers in the Cervix

Who this might be right for
Herpes Simplex Type Two InfectionHIV Infections
University of Toronto 30
Testing effectiveness (Phase 2)Looking for participantsNCT05652478
What this trial is testing

Early Metabolic Effects of Antiretroviral Drugs in Healthy volUnteers: a Phase 2 Randomized Study

Who this might be right for
Healthy VolunteerWeight GainMetabolic Effects+1 more
National Institute of Allergy and Infectious Diseases (NIAID) 120
Testing effectiveness (Phase 2)Study completedNCT00091702
What this trial is testing

Safety of and Immune Response to Two Influenza Vaccines in HIV Infected Children and Adolescents

Who this might be right for
HIV InfectionsInfluenza
National Institute of Allergy and Infectious Diseases (NIAID) 300
Early research (Phase 1)Study completedNCT04723602
What this trial is testing

Evaluation of Safety, Tolerability and Immune Responses of Ebola-S and Marburg Vaccines in Healthy Adults

Who this might be right for
Ebola Virus DiseaseMarburg Virus Disease
Albert B. Sabin Vaccine Institute 32
Not applicableUnknownNCT03931083
What this trial is testing

Screening Test Accuracy of Gynocular™, HR-HPV Testing, VIA for Detection of Cervical Neoplastic Lesions, in Women Living With HIV

Who this might be right for
Uterine Cervical NeoplasmsHIV/AIDS
University of Bern 450
Next Page